Best Grants for Teachers Continuing Education in New York

The Domestic Violence Prevention (DVP) grant from the IHS aims to enhance the capacity of Tribes and Urban Indian Organizations to combat domestic and sexual violence. This initiative promotes culturally appropriate, trauma-informed services, focusing on victim advocacy and collaboration across sectors. It addresses critical issues like human trafficking and child maltreatment, ensuring long-term sustainability through evidence-based practices and data sharing, ultimately improving community health and safety for AI/AN populations.

The Urban Indian Health 4-in-1 Program is designed to enhance the health and well-being of urban Native Americans through targeted initiatives in immunization, health promotion, disease prevention, mental health support, and addressing alcohol and substance abuse issues. Funded by the US Dept. of Health & Human Services, this program aims to improve access to essential health services and foster healthier communities among urban Indian populations.

The Youth Regional Treatment Center Aftercare Program aims to support American Indian and Alaska Native youth in maintaining safety, sobriety, and success post-discharge from Youth Regional Treatment Centers. This initiative enhances culturally relevant, community-based aftercare by fostering care coordination, building partnerships, and addressing barriers to improve youth outcomes.

The Urban Indian Health Program - Education & Research collaborates with the US Dept. of Health & Human Services to enhance educational and research opportunities for urban Indian populations. This initiative aims to address health disparities and ensure that urban Indians have access to quality health services and information. By partnering with various urban Indian organizations, the program fosters community engagement and empowers individuals through education and research, ultimately improving health outcomes.

The Suicide Prevention, Intervention, and Postvention program aims to reduce suicide rates among American Indian and Alaska Native populations. By enhancing care coordination and culturally relevant behavioral health services, it targets at-risk youth with early intervention strategies. This initiative emphasizes community engagement and collaboration among families, youth, and partners, fostering a comprehensive approach to prevention and support for those affected by suicide.

The Tribal Self-Governance Planning and Negotiation Cooperative Agreements are designed to assist tribes in planning and preparing to manage healthcare services for their members through the Tribal Self Governance Program. The Indian Health Service will provide three awards under this initiative, aiming to empower tribal organizations in their efforts to enhance healthcare delivery and self-determination.

The Tribal Management Grant program is designed to empower tribes and tribal organizations by enabling them to take over functions and services of the Indian Health Service. Under the Public Law 93-638, this initiative aims to enhance their health management capabilities, fostering self-determination and improved healthcare delivery. The Indian Health Service plans to provide between five and sixteen awards to support this vital development in tribal health management.

The Tribal Self Governance - Planning program provides essential support for tribes to prepare for managing healthcare services for their communities. Through the Cooperative Agreements, the Indian Health Service aims to empower tribal organizations to take charge of their health needs, facilitating a smoother transition to self-governance in healthcare. This initiative reflects a commitment to enhancing tribal autonomy and improving health outcomes, with three awards available to eligible applicants.

Chick-fil-A Impact Accelerator

With the goal of helping organizations sustain their purpose and scale their impact, the Chick-fil-A Impact Accelerator brings together hundreds of nonprofit leaders to learn from influential national thought leaders through a one-day conference and a 12-month cohort program. By providing training, support, and resources – and fostering connections with fellow nonprofit leaders and change makers - Chick-fil-A Impact Accelerator invites nonprofit organizations to greater long-term impact as we serve and contribute to our communities together.

Cohort Program: 12-Month Accelerated Growth Program

Nonprofit Founders and Executive Directors are invited to apply for in-depth training, development, and networking by Plywood People through a grant-funded 12-month cohort program sponsored by Chick-fil-A.

• In-Person Kick-off Training Session
• 3-Day Retreat near Atlanta
• 9 Half-Day Monthly Group Coaching Sessions

Council of Independent Colleges (CIC)Founded in 1956, the Council of Independent Colleges (CIC) is an association of nonprofit independent colleges and universities, state-based councils, and higher education affiliates that works to support college and university leadership, advance institutional excellence, and enhance public understanding of independent higher education’s contributions to society.

CIC is the major national organization that focuses on providing services to leaders of independent colleges and universities and state-based councils. CIC offers conferences, seminars, publications, and other programs and services that help institutions improve educational quality, administrative and financial performance, student outcomes, and institutional visibility.NetVUE Grants for Fostering Leadership for Communities of FaithThis grant program provides funding for institutions that are working to augment their support for students who are considering possible callings to leadership roles in communities of faith.

Grant funds should be used to develop or extend programming for students, and/or professional development for faculty members and staff, with the goal of connecting students to local faith communities and supporting them as they explore and discern their callings. Initiatives may be developed within or across a variety of academic departments and campus offices, and should involve leaders of one or more faith communities near campus. NetVUE Grants for Fostering Leadership for Communities of Faith may be requested in amounts ranging up to $60,000 for use over two years to develop new programs, or to strengthen existing programs, that support students as they consider vocations of leadership for communities of faith.

The Council of Independent Colleges

Founded in 1956, the Council of Independent Colleges (CIC) is an association of nonprofit independent colleges and universities, state-based councils, and higher education affiliates that works to support college and university leadership, advance institutional excellence, and enhance public understanding of independent higher education’s contributions to society.

CIC is the major national organization that focuses on providing services to leaders of independent colleges and universities and state-based councils. CIC offers conferences, seminars, publications, and other programs and services that help institutions improve educational quality, administrative and financial performance, student outcomes, and institutional visibility.

NetVUE Grant Programs

NetVUE offers a variety of grants to member institutions, supporting programming for students and professional development for faculty members and staff. Grants support projects ranging from one to four years in length. Grant programs are tailored to differing circumstances among member institutions, including their particular areas of interest, their bandwidth and capacity for administering projects, and the depth of their previous engagement with vocational exploration and discernment. NetVUE grants are administered by the Council of Independent Colleges, with generous support from Lilly Endowment Inc.

NetVUE Grants for Reframing the Institutional Saga

Many NetVUE member colleges and universities have strong historical ties to a specific religious tradition, a particular educational philosophy, or a pioneering educator. These elements of an institution’s heritage are important, but their significance may not always be clear in the midst of changes in the institution’s demographic profile, surrounding community, and founding organizations. These changes can influence student recruitment and retention, curriculum design, and the composition of faculty. The purpose of this grant program is to enable institutions to produce an updated account of their history and mission in light of their current context.

American Gastroenterological Association

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA represents members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization.

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease

This award provides funding for three years to early-career faculty (i.e., investigator, instructor, research associate or equivalent) working toward an independent career in inflammatory bowel disease (IBD) research.

Objective

The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for mentored research (i.e., a minimum of 50 percent effort dedicated to the proposed project). This award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research pertaining to inflammatory bowel disease.

Review all of the benefits AGA Research Scholar Award recipients are entitled to on the award policies page.

Application Requirements

• Maintain AGA membership throughout the three-year duration of the award.

• Applicants must self-assign their proposal to one of the following categories:
  • Clinical: Research involving direct contact with human subjects or using clinical data to address problems related to the prevention, diagnosis, treatment or outcome of human diseases (e.g., clinical epidemiology). This category also includes research related to health care delivery (e.g., health services, health IT).
  • Basic/Translational: Research with a primary goal of understanding basic biology or disease mechanisms. This category can involve animal subjects, cell culture, human biospecimens or human data as resources for laboratory- or informatics-based investigation.

• Resources allocated through this award are intended to support the career development of the applicant. The applicant must allocate a minimum of 50 percent effort to the proposed project.

• Applicants are required to have a sponsor and mentor for the award; one individual may serve in the capacity of both positions. A sponsor (typically a division chief or department chair) is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A mentor will supervise the principal investigator’s research activities ensuring timelines and deliverables and will work with the applicant to create a research career development plan.

• The intent of this award is to foster the scientific independence of junior investigators. Applicants whose research activities become incorporated into a grant application from a senior mentor will need to delineate clearly the scientific and experimental distinctions between their respective programs. This requirement applies both to pending applications submitted prior to review of this award and to applications submitted during the term of the RSA. It must also be clearly stated how the work submitted by the applicant is that of the applicant and not that of the senior mentor(s).

• A complete research facilities and resources form must be submitted.

• Biographical sketches for the applicant, mentor and other key personnel must be submitted.

• Applicants resubmitting a revised application from a prior cycle must include a resubmission report describing responses to reviewer feedback and other major changes since the most recent past submission.

• Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee(s) for use of human subjects or animals. If approval is not necessary, then the recipient must provide documentation from the appropriate regulatory committee.

• Recipients must submit scientific and financial progress reports to AGA annually and final reports 60 days after the end date of the award period. Report templates and instructions are provided to awardees at the time of acceptance. Second and third year funding are contingent upon the submission and accuracy of this documentation.

• All publications, presentations, abstracts, and patent applications arising from work funded by this program must acknowledge support of the AGA–Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease.

• Additional pre-award policies are available on the Research Award Policies page.

Award Overlap

• At the time of application submission, applicants may not hold, or have held, an NIH K01, K08, K23, K99, R00, R01, R21, R29, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (e.g., the American Liver Foundation, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation).

• Applicants who have held a K12 or KL2 in the past are eligible to apply. Applicants with an active K12 or KL2 may apply in the final year of their active K12 or KL2 so long as the award will end before the Research Scholar Award term begins.

• If a applicant is granted the award and notified of a comparable award from another agency prior to the first payment of this award, then the recipient must select one of the two awards (i.e., the recipient may not retain both awards).

• If the recipient is notified that a comparable award has been granted after the first payment of this award, then the recipient may retain up to 50 percent of the remainder of his or her AGA award. AGA must be notified by the recipient via email within two weeks of receiving notification of additional funding.

The Primary Biliary Cholangitis (PBC) Fund, established by the Patient Advocate Foundation, offers vital financial assistance to patients managing the costs of treatment for primary biliary cholangitis. This fund covers out-of-pocket healthcare expenses such as medication copays and health insurance premiums, enabling individuals to access necessary treatments. Since its inception, the foundation has empowered millions by providing personalized support and resources, aiming to improve patient care and health outcomes.

The Pompe Disease Health Equity Fund, supported by the Patient Advocate Foundation, offers crucial financial assistance to patients diagnosed with Pompe disease. This fund helps cover out-of-pocket healthcare costs, including medication copays and health insurance premiums. Eligibility requires a confirmed diagnosis and treatment plan, along with meeting specific income criteria. With a mission to enhance health equity, the fund empowers patients to access necessary care and improve their quality of life.

Foundation of the Federal Bar Association

The Foundation of the Federal Bar Association provides the best way for practitioners to give back to the Federal legal community. Chartered by Congress in 1954, the Foundation serves people in communities across the United States through its generous grants, scholarships, and programming.

Our Mission: The Foundation’s mission is to:

• Promote and support legal research and education;
• Advance the science of jurisprudence;
• Facilitate the administration of justice;
• Foster improvements in the practice of Federal law

Foundation Grants

Foundation grants support community service projects and civics programs which comply with the Foundation’s mission to promote and support legal research and education; advance the science of jurisprudence; facilitate the administration of justice; and foster improvements in the practice of Federal law.

Civics Education Grant

The Civics Grant Program is designed to support projects and initiatives that promote a wider public understanding of democratic principles, the judicial system and the rule of law. Through targeted funding, the program empowers FBA chapters, sections, divisions, national standing committees (FBA entity), and other organizations to develop and support projects in their communities that foster public understanding of the rights and responsibilities of American citizenship, particularly among younger Americans.

Applicants may only receive one (1) Foundation grant per year.

The Pompe Disease Fund, supported by the Patient Advocate Foundation, offers vital financial assistance to individuals diagnosed with Pompe disease. This fund covers out-of-pocket healthcare costs including medication copays and health insurance premiums. Eligible patients must have a confirmed diagnosis and be receiving treatment or planning to start within 60 days. With over 3.8 million patients helped since its inception, the fund aims to alleviate financial burdens and enhance access to necessary treatments.

Foundation of the Federal Bar Association

The Foundation of the Federal Bar Association provides the best way for practitioners to give back to the Federal legal community. Chartered by Congress in 1954, the Foundation serves people in communities across the United States through its generous grants, scholarships, and programming.

Our Mission: The Foundation’s mission is to:

• Promote and support legal research and education;
• Advance the science of jurisprudence;
• Facilitate the administration of justice;
• Foster improvements in the practice of Federal law

Elaine R. “Boots” Fisher Award

Elaine R. “Boots” Fisher was the wife of former National and Northern District of Ohio Chapter President Stanley M. Fisher. Sadly, in 1989 “Boots” Fisher succumbed to illness. The Elaine R. “Boots” Fisher Award is presented as a memorial to the outstanding and unselfish contributions made by “Boots” Fisher to improve the quality of life and opportunities of all persons. She gave of herself willingly to help others to overcome adversity.

The award is intended to stimulate, encourage and recognize exemplary community, public and charitable service by members of the Federal Bar Association. Nominations should demonstrate:

• Continuous general or specific contributions to community, charitable or public service;
• Specific accomplishments for which the nominee is primarily responsible which serve to enhance, promote and encourage community, charitable and/or public service; and
• Specific personal achievements of the nominee which serve to provide inspiration and hope to others. The charitable contribution made in the name of the recipient reflects the essence of the person in whose honor this award is established.

The charitable contribution made in the name of the recipient reflects the essence of the person in whose honor this award is established. A cash contribution in the amount of $1,000 will be made in the recipient’s name to a charity selected by the recipient. The charity selected must meet the requirements of Section 501(c)(3) of the Internal Revenue Code and contributions to charitable organizations which promote the provision of legal services and the administration of justice are encouraged but not required.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Acute Myeloid Leukemia (AML) Fund

Help with healthcare costs for acute myeloid leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Chronic Lymphocytic Leukemia (CLL) Fund

Help with healthcare costs for chronic lymphocytic leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See Approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Fund

Help with healthcare costs for hemophilia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Health Equity Fund

Help with healthcare costs for hemophilia (health equity fund)

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type III (MPS III) Fund

Help with healthcare costs for mucopolysaccharidosis type III

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Fund

Help with healthcare costs for mucopolysaccharidosis type VII

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Health Equity Fund

Help with healthcare costs for mucopolysaccharidosis type VII (health equity)

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The LEGO Foundation Fellowship

Advancing the science and practice of supporting children to thrive

The LEGO Foundation Fellowship is a global initiative supporting researchers working to deepen our understanding of how children thrive. Spanning disciplines from education and psychology to public health, data science, and humanitarian studies, the fellowship brings together early- and mid-career scholars whose work has the potential to generate evidence that matters for children’s lives.

Fellows receive three years of flexible support to pursue rigorous, practically relevant research, and join a cohort of peers working across the fellowship’s themes. In addition to funding research, the program fosters a community of scholars engaged in meaningful exchange with one another and with research, policy, and practice audiences.

The LEGO Foundation Fellowship is developed in partnership with the LEGO Foundation, and administered by SSRC as part of its commitment to supporting scholars whose work bridges research and real-world impact.

Research themes

The LEGO Foundation Fellowship welcomes research proposals that advance understanding of children’s thriving through one of the following three themes: the youngest children in crisis and conflict settings; inclusion and wellbeing of neurodivergent children; and children’s learning and development in an AI-enabled world. Applicants may explore the role of play where it is relevant to the research question. The consideration of play is optional and not a condition of eligibility.

About Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Who we are and our impact

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Eosinophilic esophagitis

Help with healthcare costs for eosinophilic esophagitis

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

About the disease

Eosinophilic Esophagitis (EoE) is a disorder of the esophagus and is increasingly recognized as a major cause of swallowing difficulties in children and adults. It is a chronic disease of the immune system and can be triggered by a food allergy, acid reflux, or an airborne allergy. An allergic trigger causes the immune system to overact which causes many white blood cells, or eosinophils, to collect in the esophagus. This causes the esophagus to become inflamed and not contract properly. The esophagus can also narrow and develop rings or abscesses. This condition can become worse over time.

About Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Who we are and our impact

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Cushing’s disease or syndrome

Help with healthcare costs for Cushing's disease or syndrome

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

About the disease

Cushing’s Disease or Syndrome, also known as Cushing’s Syndrome, hypercortisolism and hyperadrenalism, is a condition where the pituitary gland releases high levels of the hormone cortisol. It is a rare disease that affects the endocrine system.